# Eoflow invests 18B won in Eopump production facility

Eoflow announced a 18 billion won investment in facilities for in-house production of the Eopump, a core component of its wearable insulin pump, including remodeling a new factory and building an automated line in Gwangju, Gyeonggi Province.

- Type: Investment
- Announced: 2021-09-06
- Where: Gwangju, Gyeonggi Province, South Korea
- Value: $15.3M (18.0B KRW)
- Status: announced
- Capacity: monthly 1 million units
- Products: Eopump (wearable insulin pump component)
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [EOFlow](https://endata.com/companies/55385.md)

## Sources

- [etoday.co.kr](https://www.etoday.co.kr/news/view/2059791), 2021-09-06: "이오플로우는 6일 웨어러블 인슐린 펌프의 핵심부품인 이오펌프 생산시설에 180억원 규모의 투자를 진행한다고 밝혔다."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.